Pathological Gambling Clinical Trial
Official title:
Indicated Prevention With At-Risk Gamblers
Verified date | December 2013 |
Source | University of Washington |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
The overall purpose of this study is to reduce the prevalence of gambling risk in college students by evaluating the effectiveness of different treatments in reducing gambling behavior and related negative consequences.
Status | Completed |
Enrollment | 225 |
Est. completion date | July 2003 |
Est. primary completion date | July 2003 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 17 Years to 24 Years |
Eligibility |
Inclusion Criteria: - College student - South Oaks Gambling Screen (SOGS) score greater than 3 Exclusion Criteria: - None, other than not meeting inclusion criteria |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | University of Washington; Department of Psychiatry and Behavioral Sciences | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
University of Washington | National Institute of Mental Health (NIMH) |
United States,
Larimer ME, Neighbors C, Lostutter TW, Whiteside U, Cronce JM, Kaysen D, Walker DD. Brief motivational feedback and cognitive behavioral interventions for prevention of disordered gambling: a randomized clinical trial. Addiction. 2012 Jun;107(6):1148-58. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | South Oaks Gambling Screen (SOGS) | The 20-item South Oaks Gambling Screen (SOGS) measures gambling involvement and problem severity based on DSM-III-R pathological gambling criteria. | 6-Months | No |
Primary | Gambling Quantity and Perceived Norms Scale (GQPN) | The gambling quantity and perceived norms scale (GQPN) includes a six-item expenditure subscale assessing amount of money won/lost through gambling on a 10-point scale from $0 to more than $2000 over time-periods from the past month to past year. Additional items assess gambling frequency (on a 10-point scale from never to every day in the past year), disposable income (on an 11-point scale from less than $50 to more than $500 per month) and perceptions of gambling frequency and expenditure for the typical college student (perceived norms). Gambling expenditure was calculated as the expenditure subscale mean residualized on disposable income. | 6 Months | No |
Primary | Gambling Frequency (SOGS) | The SOGS was modified to assess internet gambling frequency and expand gambling frequency response options from a three- to a five-point scale with anchors of no times, one to 10 times, more than 10 times, less than weekly, weekly or more than weekly but less than daily, and daily. This modified frequency scale has been shown to correlate highly with other measures of gambling frequency. | 6 Months | No |
Primary | Gambling Problems Index (GPI) | Gambling problems (or negative consequences) were assessed using the 20-item Gambling Problems Index (GPI). Participants indicated how often, from never to more than 10 times in the past 6 months, they experienced consequences while, or as a result of, gambling. | 6 Months | No |
Primary | National Opinion Research Center DSM-IV Screen for Pathological Gambling (NODS) | DSM-IV [1] criteria for pathological gambling were assessed using the 17-item National Opinion Research Center DSM-IV Screen (NODS). Some criteria have multiple items, but possible scores range from 0-10 DSM-IV criteria endorsed in the past 6 months. | 6 Months | No |
Secondary | Illusions of Control | Illusions of control were assessed via a six-item subscale from the Beliefs About Control Scale (BACS), on a five-point scale ranging from strongly disagree to strongly agree. | 6 Months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02590211 -
Poker, Skills and Associated Problems
|
N/A | |
Completed |
NCT02203786 -
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
|
Phase 2 | |
Completed |
NCT05051085 -
Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling
|
N/A | |
Completed |
NCT01215357 -
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
|
Phase 2 | |
Terminated |
NCT00245583 -
Topiramate in the Treatment of Pathological Gambling
|
Phase 3 | |
Completed |
NCT04842461 -
Mental Health, Addictions and Biomarkers in High Athletes Performance
|
||
Not yet recruiting |
NCT03280966 -
Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder
|
Phase 2 | |
Active, not recruiting |
NCT01743092 -
Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment
|
N/A | |
Active, not recruiting |
NCT01528982 -
Susceptibility to Pathological Gambling
|
N/A | |
Terminated |
NCT00211822 -
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
|
N/A | |
Completed |
NCT01381250 -
Effects of Internet-based Treatment of Pathological Gambling
|
N/A | |
Completed |
NCT05506384 -
Treatment Study for Problematic Gaming and Gambling
|
N/A | |
Enrolling by invitation |
NCT03464838 -
Effects of Transcranial Direct Current Stimulation (tDCS) in Gambling Disorder
|
N/A | |
Terminated |
NCT01560351 -
Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study
|
N/A | |
Completed |
NCT00580567 -
Impulsivity in Pathological Gambling
|
N/A | |
Completed |
NCT02240485 -
Integrative Couple Treatment for Pathological Gambling
|
N/A | |
Withdrawn |
NCT01340274 -
Community Reinforcement Approach and Family Training (CRAFT) for Problem Gambling
|
Phase 2 | |
Recruiting |
NCT02491996 -
The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers
|
N/A | |
Recruiting |
NCT01154712 -
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
|
Phase 1 | |
Completed |
NCT00927563 -
Tolcapone Treatment of Pathological Gambling
|
Phase 2 |